Search

everythinglearnresearchcommunity

for

Search:↓

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Glycated hemoglobin is not as effective as the oral glucose tolerance test for diagnosing blood sugar problems in women with PCOS in Southern Iraq.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

People with androgenetic alopecia may have higher cholesterol and triglycerides, suggesting a higher risk of heart disease.

The HSD3B1 variant increases hair loss risk in overweight women with PCOS.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

Transglutaminases work through a ping-pong mechanism, and human plasma and platelet transglutaminases have similar catalytic subunits.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

The document concludes that measuring γ-glutamyl transpeptidase activity is more accurate with a higher substrate concentration and using diluted acetic acid to stop the reaction.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

The new delivery system improves Alzheimer's symptoms by releasing Huperzine A slowly and effectively.

Higher homocysteine levels may inhibit hair growth and are linked to androgenetic alopecia.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Microneedle-delivered polyglutamate effectively and safely improves hair growth in androgenetic alopecia.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

More research is needed to understand if GLP-1 agonists affect hair health.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Higher myostatin and insulin resistance are linked to androgenetic alopecia.

Immune activities and specific genes are important in male pattern baldness.

Gene variations may increase oxidative stress in male pattern baldness.

High 1-hour plasma glucose in PCOS increases risks of metabolic issues and gestational diabetes.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Ultra-high molecular weight poly-γ-glutamic acid may help promote hair growth.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.